Experienced in Angiomyoma

Dr. Nonyem A. Onujiogu

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Beacon Medical Group Inc
100 Navarre Pl, 4470 Bmg Womens Surgical G, 
South Bend, IN 
Accepting New Patients
Offers Telehealth
Experienced in Angiomyoma
Beacon Medical Group Inc
100 Navarre Pl, 4470 Bmg Womens Surgical G, 
South Bend, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nonyem Onujiogu is a Gynecologic Oncologist and an Oncologist in South Bend, Indiana. Dr. Onujiogu is rated as an Experienced provider by MediFind in the treatment of Angiomyoma. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Hysterectomy, and Oophorectomy. Dr. Onujiogu is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in IN
Hospital Affiliations
Lakeland Hospital, St Joseph
Elkhart General Hospital
Memorial Hospital Of South Bend
Franciscan Health Michigan City
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Sunshine Health
  • EPO
  • HMO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

BEACON MEDICAL GROUP INC
100 Navarre Pl, 4470 Bmg Womens Surgical G, South Bend, IN 46601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Drug, Procedure
Study Drugs: Carboplatin, Letrozole, Paclitaxel
Study Phase: Phase 3
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
Enrollment Status: Unknown
Publish Date: March 29, 2023
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Other, Drug, Biological
Study Drugs: Dactinomycin, Leucovorin Calcium, Methotrexate
Study Phase: Phase 3
View 5 Less Clinical Trials

2 Total Publications

DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1.
DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1.
Journal: BMC cancer
Published: February 04, 2012
Similar Doctors
Experienced in Angiomyoma
Dr. Uthman Cavallo
Obstetrics and Gynecology
Experienced in Angiomyoma
Dr. Uthman Cavallo
Obstetrics and Gynecology
611 E Douglas Rd, Suite 408, 
Mishawaka, IN 
 (4.3 miles away)
574-335-6400
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Uthman Cavallo is an Obstetrics and Gynecologist in Mishawaka, Indiana. Dr. Cavallo is rated as an Advanced provider by MediFind in the treatment of Angiomyoma. His top areas of expertise are Painful Menstrual Periods, Mittelschmerz, Neuralgia, Menorrhagia, and Intrauterine Device Insertion. Dr. Cavallo is currently accepting new patients.

Experienced in Angiomyoma
Dr. Anna V. Hoekstra
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Experienced in Angiomyoma
Dr. Anna V. Hoekstra
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

West Michigan Cancer Center

200 N Park St, 
Kalamazoo, MI 
 (54.2 miles away)
269-373-7453
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anna Hoekstra is a Gynecologic Oncologist and an Oncologist in Kalamazoo, Michigan. Dr. Hoekstra is rated as a Distinguished provider by MediFind in the treatment of Angiomyoma. Her top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Oophorectomy, and Hysterectomy. Dr. Hoekstra is currently accepting new patients.

Matthew Tipton
Advanced in Angiomyoma
Dr. Matthew Tipton
Obstetrics and Gynecology
Advanced in Angiomyoma
Dr. Matthew Tipton
Obstetrics and Gynecology

NorthShore Health Centers

2200 Grant St, 
Gary, IN 
 (57.6 miles away)
219-763-8112
Languages Spoken:
English
See accepted insurances

Dr. Tipton is committed to the field of medicine to revitalize communities such as his hometown of Gary, IN. Through pathways laid out by role models, he was able to achieve his dream. His ultimate goal is to inspire young people in his community and demonstrate to them that anything is possible.Dr. Tipton’s family is deeply rooted in Northwest Indiana, including his life with his wife, Dr. Cydney Bullock-Tipton. He enjoys all types of activities with her. He is also a huge sports fan (Go Bulls/Bears/Sox!) and has a strong passion for hip-hop music. Dr. Tipton is rated as an Advanced provider by MediFind in the treatment of Angiomyoma. His top areas of expertise are Chlamydia, Vaginal Cysts, Vaginal Dryness, Trichomoniasis, and Intrauterine Device Insertion.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Onujiogu's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile